Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
Binary News Network
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
Zexprwire
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
24
25
Next >
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
Today 16:31 EDT
From
Prelude Therapeutics, Incorporated
Via
GlobeNewswire
Tickers
PRLD
Docusign Stock Rises On Q4 Earnings Beat, Strong Guidance, Bigger Buyback
↗
Today 16:30 EDT
Via
Benzinga
Topics
Earnings
Tickers
DOCU
Exposures
Financial
$100 Invested In EMCOR Group 20 Years Ago Would Be Worth This Much Today
↗
Today 16:30 EDT
Via
Benzinga
Thrawn Launches AI-Powered Scheduling Service to Eliminate Hundreds of Hours of Manual Work for Residency Programs
Today 16:30 EDT
Via
AB Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
Today 16:30 EDT
Via
TheNewswire.com
Tickers
BVAXF
CSE:BIOV
Boost Your Online Authority with Content Marketing
↗
Today 16:29 EDT
Via
Talk Markets
Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor
Today 16:30 EDT
From
Oklo Inc.
Via
Business Wire
Tickers
OKLO
Beazer Homes Announces Expansion of Revolving Credit Facility to $525 million
Today 16:30 EDT
From
Beazer Homes USA, Inc.
Via
Business Wire
Tickers
BZH
Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026
Today 16:30 EDT
From
Frontier Medicines Corporation
Via
Business Wire
NVIDIA Nemotron Powers Ceramic Supervised Generation to Ground AI Responses at Enterprise Scale
Today 16:30 EDT
From
Ceramic
Via
Business Wire
Professional Gutter filter installation in Woodlands, TX
↗
Today 16:29 EDT
Via
Talk Markets
Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026
Today 16:30 EDT
From
Pheast Therapeutics
Via
Business Wire
BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026
Today 16:30 EDT
From
BlossomHill Therapeutics, Inc.
Via
GlobeNewswire
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026
Today 16:30 EDT
From
Akamis Bio
Via
Business Wire
SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting
Today 16:30 EDT
From
SingleCell Biotechnology
Via
Business Wire
Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026
Today 16:30 EDT
From
Soley Therapeutics
Via
Business Wire
Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026
Today 16:30 EDT
From
Onchilles Pharma
Via
Business Wire
Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026
Today 16:30 EDT
From
Orum Therapeutics
Via
Business Wire
Parsons Announces New Chief Human Resources Officer
Today 16:30 EDT
From
Parsons Services Company
Via
GlobeNewswire
Tickers
PSN
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Today 16:30 EDT
From
Anbio Biotechnology
Via
GlobeNewswire
Tickers
NNNN
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Today 16:30 EDT
From
ImageneBio, Inc.
Via
GlobeNewswire
Tickers
IMA
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
Today 16:30 EDT
From
Immunocore Holdings plc
Via
GlobeNewswire
Tickers
IMCR
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
Today 16:30 EDT
From
TransAlta Corporation
Via
GlobeNewswire
Tickers
TAC
TSX:TA
TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares
Today 16:30 EDT
From
TransAlta Corporation
Via
GlobeNewswire
Tickers
TAC
TSX:TA
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Today 16:30 EDT
From
Olema Oncology
Via
GlobeNewswire
Tickers
OLMA
Molecular Partners to Hold Three Poster Presentations at AACR 2026
Today 16:30 EDT
From
Molecular Partners
Via
GlobeNewswire
Tickers
MOLN
Should You Buy the 3 Highest-Paying Dividend Stocks on the TSX? (One Recently Yielded 16.8%.)
↗
Today 16:30 EDT
Via
The Motley Fool
Tickers
TSX-V:DE
TSX:ENB
NVIDIA Rally? The Market Hasn’t Seen Anything Yet
↗
Today 16:30 EDT
Via
MarketBeat
Tickers
NVDA
Robert August Unveils The Berwyn Ave. Knit Trainer, a Fusion of Custom Style and Everyday Comfort
Today 16:29 EDT
Via
AB Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Masonite International Corporation Common Stock of Class Action Lawsuit and Upcoming Deadlines – DOOR
Today 16:28 EDT
From
Pomerantz LLP
Via
GlobeNewswire
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
24
25
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.